Skip navigation
  • Home
  • Browse
    • Communities
      & Collections
    • Browse Items by:
    • Publication Date
    • Author
    • Title
    • Subject
    • Department
  • Sign on to:
    • My MacSphere
    • Receive email
      updates
    • Edit Profile


McMaster University Home Page
  1. MacSphere
  2. Open Access Dissertations and Theses Community
  3. Open Access Dissertations and Theses
Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/11377
Full metadata record
DC FieldValueLanguage
dc.contributor.advisorLichty, Brianen_US
dc.contributor.advisorBowdish, Dawnen_US
dc.contributor.advisorBowdish, Dawnen_US
dc.contributor.authorSmith, Elspeth K.en_US
dc.date.accessioned2014-06-18T16:54:27Z-
dc.date.available2014-06-18T16:54:27Z-
dc.date.created2011-09-28en_US
dc.date.issued2011-10en_US
dc.identifier.otheropendissertations/6348en_US
dc.identifier.other7379en_US
dc.identifier.other2262852en_US
dc.identifier.urihttp://hdl.handle.net/11375/11377-
dc.description.abstract<p>Autophagy is a cellular process in which cytoplasmic material is lysosomally degraded into its basic components. The primary functions of this process are cellular recycling and stress mitigation however it also has roles in both viral pathogenesis and tumourigenesis. Beclin1 is a key mediator of autophagy and is involved in its initiation. In an attempt to examine the effects of enhanced autophagy in the context of oncolytic VSV infection, a VSV mutant (ΔM51) expressing Beclin1 was constructed and characterized. It was determined through western blot analysis of autophagy marker LC3, that while VSV infection enhanced autophagy in infected cells, Beclin1 expression resulted in a transient increase in autophagy followed by markedly reduced levels of autophagy at mid to late time points. Still, Beclin1expression, either directly or possibly through altering the kinetics of VSV induced autophagy, enhanced the pathogenesis of VSV<em> </em>in some cell lines <em>in vitro</em>. However examination of the <em>in vivo</em> pathogenesis of VSV-Belcin1 elicited no differences from that of the parental virus. Despite enhanced pathogenesis in CT26 cells <em>in vitro</em>, VSV-Beclin1 displayed no improvement in the oncolysis of CT26 tumours <em>in vivo</em>, compared to VSV-GFP. It is hoped that the conclusions drawn from this study will help direct future research aimed at exploring the relationship between autophagy and VSV pathogenesis as well as future attempts to arm VSV with the intent of augmenting its oncolytic potential.</p>en_US
dc.subjectautophagy oncolytic viral pathogenesis apoptosis rapamycin VSVen_US
dc.subjectMedical Immunologyen_US
dc.subjectMedical Pathologyen_US
dc.subjectMedical Immunologyen_US
dc.titleCHARACTERIZATION OF ΔM51-VSV EXPRESSING BECLIN1en_US
dc.typethesisen_US
dc.contributor.departmentMedical Sciencesen_US
dc.description.degreeMaster of Science (MSc)en_US
Appears in Collections:Open Access Dissertations and Theses

Files in This Item:
File SizeFormat 
fulltext.pdf
Open Access
1.35 MBAdobe PDFView/Open
Show simple item record Statistics


Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.

Sherman Centre for Digital Scholarship     McMaster University Libraries
©2022 McMaster University, 1280 Main Street West, Hamilton, Ontario L8S 4L8 | 905-525-9140 | Contact Us | Terms of Use & Privacy Policy | Feedback

Report Accessibility Issue